La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Japan Lifeline Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

5.5%

Tasso di crescita degli utili

6.2%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	13.7%
Tasso di crescita dei ricavi	3.4%
Rendimento futuro del capitale proprio	13.3%
Copertura analitica	Low
Ultimo aggiornamento	02 Aug 2024

Aggiornamenti recenti sulla crescita futura

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

Aug 04

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

May 06

Recent updates

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

Aug 04

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

May 06

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Mar 02

Previsioni di crescita degli utili e dei ricavi

TSE:7575 - Stime future degli analisti e dati finanziari passati (JPY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
3/31/2027	58,266	8,439	7,274	N/A	4
3/31/2026	57,149	8,583	6,617	N/A	4
3/31/2025	54,469	8,155	6,354	N/A	4
6/30/2024	52,440	7,525	N/A	N/A	N/A
3/31/2024	51,384	7,515	4,578	6,918	N/A
12/31/2023	51,554	8,493	N/A	N/A	N/A
9/30/2023	51,393	7,222	5,669	7,074	N/A
6/30/2023	51,735	7,275	N/A	N/A	N/A
3/31/2023	51,750	6,891	9,472	11,201	N/A
12/31/2022	50,958	6,533	N/A	N/A	N/A
9/30/2022	51,828	7,595	9,533	11,359	N/A
6/30/2022	51,826	7,728	N/A	N/A	N/A
3/31/2022	51,469	7,484	8,388	10,246	N/A
12/31/2021	51,967	7,274	N/A	N/A	N/A
9/30/2021	51,963	2,807	11,629	13,093	N/A
6/30/2021	52,430	2,857	N/A	N/A	N/A
3/31/2021	51,286	2,000	10,339	11,432	N/A
12/31/2020	52,072	2,240	N/A	N/A	N/A
9/30/2020	52,041	6,977	6,804	8,610	N/A
6/30/2020	51,444	6,653	N/A	N/A	N/A
3/31/2020	51,761	7,748	4,526	7,096	N/A
12/31/2019	49,785	8,033	N/A	N/A	N/A
9/30/2019	47,433	7,640	5,181	7,151	N/A
6/30/2019	46,253	8,003	N/A	N/A	N/A
3/31/2019	45,525	7,723	5,238	7,037	N/A
12/31/2018	44,903	7,557	N/A	N/A	N/A
9/30/2018	44,296	7,730	2,390	4,702	N/A
6/30/2018	43,127	7,304	N/A	N/A	N/A
3/31/2018	42,298	7,478	N/A	4,450	N/A
12/31/2017	41,069	6,904	N/A	N/A	N/A
9/30/2017	39,577	6,364	N/A	5,359	N/A
6/30/2017	38,504	5,990	N/A	N/A	N/A
3/31/2017	37,181	5,350	N/A	6,584	N/A
12/31/2016	36,105	4,460	N/A	N/A	N/A
9/30/2016	34,452	3,790	N/A	5,740	N/A
6/30/2016	32,701	3,019	N/A	N/A	N/A
3/31/2016	30,540	2,804	N/A	916	N/A
12/31/2015	28,536	2,538	N/A	N/A	N/A
9/30/2015	27,392	2,224	N/A	-2,297	N/A
6/30/2015	26,454	2,088	N/A	N/A	N/A
3/31/2015	25,696	1,124	N/A	1,245	N/A
12/31/2014	25,043	-126	N/A	N/A	N/A
9/30/2014	24,713	-213	N/A	1,320	N/A
6/30/2014	24,477	-381	N/A	N/A	N/A
3/31/2014	24,371	-202	N/A	-374	N/A
12/31/2013	23,705	855	N/A	N/A	N/A
9/30/2013	23,052	598	N/A	128	N/A

Japan Lifeline Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

Price target increased by 11% to JP¥1,400

Price target increased by 11% to JP¥1,258

Price target increased by 13% to JP¥1,280

Japan Lifeline Co., Ltd. Revises Financial Forecast of Consolidated Financial Results for the Year Ending March 31, 2023

Recent updates

Japan Lifeline Co., Ltd. to Report Q2, 2025 Results on Oct 31, 2024

Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report

New major risk - Revenue and earnings growth

First quarter 2025 earnings released: EPS: JP¥31.94 (vs JP¥30.03 in 1Q 2024)

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥42.00 per share

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Japan Lifeline Co., Ltd. to Report Q4, 2024 Results on May 01, 2024

Price target increased by 11% to JP¥1,400

Third quarter 2024 earnings released: EPS: JP¥28.32 (vs JP¥11.15 in 3Q 2023)

Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Price target increased by 11% to JP¥1,258

New major risk - Revenue and earnings growth

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

Second quarter 2024 earnings released: EPS: JP¥22.31 (vs JP¥22.54 in 2Q 2023)

Price target increased by 13% to JP¥1,280

Now 23% undervalued

Now 21% undervalued

Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023

Now 23% undervalued

First quarter 2024 earnings released: EPS: JP¥30.02 (vs JP¥24.73 in 1Q 2023)

Japan Lifeline Co., Ltd. to Report Q2, 2024 Results on Nov 06, 2023

Full year 2023 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Upcoming dividend of JP¥38.00 per share at 4.1% yield

Japan Lifeline Co., Ltd. Revises Financial Forecast of Consolidated Financial Results for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥11.15 (vs JP¥24.01 in 3Q 2022)

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Japan Lifeline Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023

Consensus forecasts updated

Japan Lifeline Co., Ltd. Launches Series of In-House Products for Biliary-Pancreatic Endoscopy

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Japan Lifeline Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: EPS: JP¥24.73 (vs JP¥21.17 in 1Q 2022)

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Year Ending March 31, 2023

Japan Lifeline Co., Ltd. to Report Q2, 2023 Results on Nov 02, 2022

Price target decreased to JP¥1,120

Japan Lifeline Co., Ltd. Announces Dividend for Year Ended March 31, 2022, Effective Date Is June 29, 2022

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2022

Consensus EPS estimates fall by 12%

Japan Lifeline Co., Ltd. Appoints Shigeki Kitayama as Operating Officer

Upcoming dividend of JP¥38.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022

Price target decreased to JP¥1,500

Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year of Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥21.17 (vs JP¥10.53 in 1Q 2021)

Metcela Inc. and Japan Lifeline Co., Ltd. Announces Initiation of Phase I Clinical Trial of MTC001 in Patients with Chronic Ischemic Heart Failure

VP, GM of CRM Business Division & Director Osamu Watanabe has left the company

Japan Lifeline Receives Regulatory Approval for HeartLight X3

Japan Lifeline Co., Ltd. Receives Regulatory Approval for Abdominal Stent Graft Alto

Full year 2021 earnings released: EPS JP¥24.90 (vs JP¥96.55 in FY 2020)

Japan Lifeline Co., Ltd. Provides Year End Cash Dividend Guidance for the Year Ending March 31, 2022

Consensus forecasts updated

Upcoming dividend of JP¥49.00 per share

New 90-day low: JP¥1,365

Cardiofocus, Inc. Announces Expanded Partnership with Japan Lifeline Co., Ltd

Third quarter 2021 earnings released: JP¥31.57 loss per share (vs JP¥27.44 profit in 3Q 2020)